AMANDA BRINK: Open Payments
NPI 1568871101 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,455 in 17 payments from 14 companies in 2025. Trend: 2023 $2,487 · 2024 $2,890 · 2025 $1,455
Food & beverage: $1,363Honoraria: $58Speaker / faculty: $34
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 2 | $206 |
| Janssen Biotech, Inc. | 2 | $164 |
| Abbott Laboratories | 1 | $146 |
| Amgen Inc. | 1 | $138 |
| Pharmacosmos Therapeutics Inc. | 1 | $125 |
| Xeris Pharmaceuticals, Inc. | 1 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $100 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $96 |
| Becton, Dickinson and Company | 2 | $92 |
| Gilead Sciences, Inc. | 1 | $87 |
Products named: Korlym, RYBREVANT, PROCLAIM, COSELA, RECORLEV, Vitrakvi, JOURNAVX, Epclusa.
Industry payments across TX — which companies pay providers there.
